Immuneering (IMRX) Shares Outstanding (2020 - 2026)
Immuneering (IMRX) posted quarterly Shares Outstanding (Entity) of $64.7 million for Q1 2026, up 79.76% year-over-year from $36.0 million in Q1 2025, and up 46.98% quarter-over-quarter from $44.0 million in Q4 2025.
Immuneering (IMRX) Shares Outstanding (2020 - 2026) Analysis & Trends
Immuneering's Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $64.7 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 79.76% year-over-year to $64.7 million; the TTM figure through Mar 2026 stood at $64.7 million (up 79.76% YoY), while the FY2025 annual figure was $44.0 million, up 41.74% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $64.7 million, up from $44.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $64.7 million in Q1 2026, with the low at $26.4 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $29.7 million (2024), against an average of $33.0 million.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) surged 432.98% in 2022, then climbed 0.43% in 2023.
- Immuneering's Shares Outstanding (Entity) stood at $26.4 million in 2022, then advanced by 10.8% to $29.3 million in 2023, then climbed by 6.08% to $31.1 million in 2024, then soared by 41.74% to $44.0 million in 2025, then jumped by 46.98% to $64.7 million in 2026.
- Business Quant data shows IMRX's Shares Outstanding (Entity) at $64.7 million in Q1 2026, $44.0 million in Q4 2025, and $39.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Immuneering | 327.37 Mn | 327.37 Mn | - | 64.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 64.70 Mn |
| Mar 31, 2026 | 64.66 Mn |
| Dec 31, 2025 | 44.01 Mn |
| Sep 30, 2025 | 39.67 Mn |
| Jun 30, 2025 | 35.99 Mn |
| Mar 31, 2025 | 35.53 Mn |
| Dec 31, 2024 | 29.98 Mn |
| Sep 30, 2024 | 29.84 Mn |
| Jun 30, 2024 | 29.65 Mn |
| Mar 31, 2024 | 29.37 Mn |
| Dec 31, 2023 | 28.42 Mn |
| Sep 30, 2023 | 29.27 Mn |
| Jun 30, 2023 | 28.65 Mn |
| Mar 31, 2023 | 26.44 Mn |
| Dec 31, 2022 | 26.39 Mn |
| Sep 30, 2022 | 26.39 Mn |
| Jun 30, 2022 | 26.39 Mn |
| Mar 31, 2022 | 26.36 Mn |
| Dec 31, 2021 | 13.61 Mn |
| Sep 30, 2021 | 18.29 Mn |